Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Index funds often deliver steady returns due to broad diversification and low costs; learn how this supports long-term growth.
25,349 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
U.S. Q1 GDP was revised higher to a 2.1% annualized pace, topping prior estimates. The gain sparks relief in markets ...
Twilio stocks have seen a pullback after a strong run. This guide explains how to assess whether you should twilio di...
Anthropic’s looming IPO could reshape AI investing. With a private valuation near the hundreds of billions and big te...
When a state tightens its grip on fraud, honest families feel the impact first. Alaska's Medicaid crackdown underscor...
When markets swing on news and surprises, traders crave flexibility. The cboe global markets launch of extended hours...
A Utah-based defamation suit accuses Kevin O’Leary and Fox News of tying two local political groups to the CCP amid o...
DocMagic promotes Leah Sommerville to director of sales, signaling a bold push toward enterprise-wide paperless closi...
Eight trade groups push lower capital charges for mortgage servicing rights and advocate for tailored risk weights, a...
Tariff policy volatility follows a high court ruling, and a new AI platform aims to help firms weather the disruption...
Block Inc. announced a sweeping AI-driven overhaul that cuts roughly 4,000 jobs, moving headcount from just over 10,0...
Target reports a Q4 EPS beat on margin gains even as customer visits declined. The results highlight a bifurcated pat...